Mechanical and electrophysiological effects of a hydroxyphenyl-substituted tetrahydroisoquinoline, SL-1, on isolated rat cardiac tissues

被引:3
作者
Chang, GJ
Su, MJ
Lee, PH
Lee, SS
Liu, KCS
机构
[1] NATL TAIWAN UNIV, COLL MED, INST PHARMACOL, TAIPEI 10764, TAIWAN
[2] NATL TAIWAN UNIV, COLL MED, SCH PHARM, TAIPEI 10764, TAIWAN
关键词
SL-1; tetrahydroisoquinoline; inotropic and chronotropic action; action potential; Na+; Ca2+; and K+ currents;
D O I
10.1139/y95-727
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanisms of the positive inotropic action of a new synthetic tetrahydroisoquinoline compound, SL-1, were investigated in isolated rat cardiac tissues and ventricular myocytes. SL-I produced a rapidly developing, concentration-dependent positive inotropic response in both atrial and ventricular muscles and a negative chronotropic effect in spontaneously beating right atria. The positive inotropic effect was not prevented by pretreatment with reserpine (3 mg/kg) or the alpha-adrenoceptor antagonist prazosin (1 mu M), but was suppressed by either the beta-adrenoceptor antagonist atenolol (3 mu M) or the K+ channel blocker 4-aminopyridine (4AP, 1 mM). In the whole-cell recording study, SL-1 increased the plateau level and prolonged the action potential duration in a concentration-dependent manner and decreased the maximum upstroke velocity (V-max) and amplitude of the action potential in isolated rat ventricular myocytes stimulated at 1.0 Hz. On the other hand, SL-1 had little effect on the resting membrane potential, although it caused a slight decrease at higher concentrations. Voltage clamp experiments revealed that the increase of action potential plateau and prolongation of action potential duration were associated with an increase of Ca2+ inward current (I-Ca) via the activation of beta-adrenoceptors and a prominent inhibition of 4AP-sensitive transient outward K+ current (I-to) with an IC50 of 3.9 mu M. Currents through the inward rectifier K+ channel (I-K1) Were also reduced. The inhibition of I-to is characterized by a reduction in peak amplitude and a marked acceleration of current decay but without changes on the voltage dependence of steady-state inactivation. In addition to the inhibition of K+ currents, SL-1 also inhibited the Na+ inward current (I-Na) with an IC50 of 5.4 mu M, which was correlated with the decrease of V-max. We conclude that the positive inotropic effect of SL-1 may be due to an increase in Ca2+ current mediated via partial activation of beta-adrenoceptors and an inhibition of K+ outward currents and the subsequent prolongation of action potentials.
引用
收藏
页码:1651 / 1660
页数:10
相关论文
共 36 条
[1]  
ASOKE M, 1985, J PHARMACOL EXP THER, V232, P1
[2]   DIGITALIS INTOXICATION - PROSPECTIVE CLINICAL STUDY WITH SERUM LEVEL CORRELATIONS [J].
BELLER, GA ;
SMITH, TW ;
ABLEMANN, WH ;
HABER, E ;
HOOD, WB .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (18) :989-+
[3]   ADRENERGIC MODULATION OF THE DELAYED RECTIFIER POTASSIUM CHANNEL IN CALF CARDIAC PURKINJE-FIBERS [J].
BENNETT, P ;
MCKINNEY, L ;
BEGENISICH, T ;
KASS, RS .
BIOPHYSICAL JOURNAL, 1986, 49 (04) :839-848
[4]  
CASTLE NA, 1993, J PHARMACOL EXP THER, V264, P1450
[5]   PHARMACOLOGICAL CHARACTERIZATION OF EFFECTS OF VERAPAMIL AND GS-283 ON ISOLATED GUINEA-PIG AND RAT TRACHEALIS [J].
CHANG, KC ;
KO, HJ ;
CHO, SD ;
YOON, YJ ;
KIM, JH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236 (01) :51-60
[6]   PHARMACOLOGICAL EVALUATION OF GS-389, A NOVEL TETRAHYDROISOQUINOLINE ANALOG RELATED TO HIGENAMINE, ON VASCULAR SMOOTH-MUSCLE [J].
CHANG, KC ;
LIM, JK ;
PARK, CW .
LIFE SCIENCES, 1992, 51 (01) :67-74
[7]   DIFFERENT PHARMACOLOGICAL CHARACTERISTICS OF STRUCTURALLY SIMILAR BENZYLISOQUINOLINE ANALOGS, PAPAVERINE, HIGENAMINE, AND GS-389, ON ISOLATED RAT AORTA AND HEART [J].
CHANG, KC ;
CHONG, WS ;
LEE, IJ .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1994, 72 (04) :327-334
[8]  
CHANG KC, 1981, KOREAN J PHARM, V17, P59
[9]  
DAVIDSON C, 1973, BRIT HEART J, V35, P970
[10]   CARDIOVASCULAR EFFECTS OF SUBSTITUTED TETRAHYDROISOQUINOLINES IN RATS [J].
DONG, H ;
LEE, CM ;
HUANG, WL ;
PENG, SX .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (01) :262-268